In view of Japan’s declining birth rate due to late marriage and birth rates decline, infertility treatment is important and “Assisted Reproductive Technology” (ART) has been positioned as an important therapy against refractory infertility. Progesterone is considered as luteal supplement, and Ferring Pharmaceuticals has obtained regulatory approval to sell 100 mg tablets from December, 2014.

Ferring Pharmaceuticals news release, Nov. 26, 2014